Merlin (protein): Difference between revisions

Latest revision as of 17:05, 29 December 2024

Merlin, also known as neurofibromin 2 (NF2), is a protein that in humans is encoded by the NF2 gene. It is a member of the ERM family of proteins, which includes ezrin, radixin, and moesin. These proteins are involved in linking the cytoskeleton to the cell membrane.

Function[edit]

Merlin is a tumor suppressor protein that is involved in the regulation of cell growth and cell adhesion. It plays a critical role in maintaining the stability of cell junctions and the cytoskeleton. Merlin is known to inhibit the Ras signaling pathway, which is important for controlling cell proliferation.

Clinical significance[edit]

Mutations in the NF2 gene can lead to the development of neurofibromatosis type II, a disorder characterized by the growth of noncancerous tumors in the nervous system, particularly schwannomas and meningiomas. Patients with neurofibromatosis type II often experience hearing loss, balance problems, and other neurological symptoms.

Interactions[edit]

Merlin interacts with several other proteins, including CD44, beta-catenin, and Rac1. These interactions are important for its role in cell signaling and maintaining cell structure.

Research[edit]

Ongoing research is focused on understanding the precise mechanisms by which merlin functions as a tumor suppressor and how its loss leads to tumor development. Studies are also exploring potential therapeutic strategies to target merlin-deficient tumors.

References[edit]

External links[edit]

@@ Line 1: / Line 1: @@
-'''Merlin''' (also known as '''Moesin-Ezrin-Radixin-Like Protein''' or '''Neurofibromin 2''') is a [[protein]] that in humans is encoded by the ''NF2'' [[gene]]. It is a member of the [[band 4.1 superfamily]] of proteins, which link the [[cytoskeleton]] to the [[cell membrane]]. Merlin is particularly important in [[nervous system]] cells, and mutations in the ''NF2'' gene can lead to [[neurofibromatosis type II]], a genetic condition characterized by the growth of noncancerous tumors in the nervous system.
-==Structure==
+{{Infobox protein
-Merlin is a 70-kDa protein that is composed of a [[FERM domain]] at the N-terminus, an [[alpha-helical]] domain in the middle, and a [[C-terminal]] domain. The FERM domain is responsible for the protein's interaction with the cell membrane, while the alpha-helical and C-terminal domains are involved in protein-protein interactions.
+| name = Merlin
+| image = <!-- Image removed -->
+| caption = <!-- Caption removed -->
+| symbol = NF2
+| alt_symbols = SCH
+| EntrezGene = 4771
+| HGNCid = 7773
+| OMIM = 101000
+| RefSeq = NM_000268
+| UniProt = P35240
+| PDB = 1ISN
+}}
-==Function==
+'''Merlin''', also known as '''neurofibromin 2''' ('''NF2'''), is a [[protein]] that in humans is encoded by the [[NF2 gene]]. It is a member of the [[ERM family]] of proteins, which includes [[ezrin]], [[radixin]], and [[moesin]]. These proteins are involved in linking the [[cytoskeleton]] to the [[cell membrane]].
-Merlin plays a crucial role in several cellular processes, including [[cell cycle]] regulation, [[cell adhesion]], and [[cell migration]]. It acts as a [[tumor suppressor]] by inhibiting the activity of certain proteins that promote cell division and survival. In the nervous system, Merlin helps to maintain the structure and function of [[Schwann cells]], which produce the [[myelin sheath]] that insulates nerve fibers.
-==Clinical significance==
+== Function ==
-Mutations in the ''NF2'' gene can lead to neurofibromatosis type II. This condition is characterized by the growth of [[schwannomas]], benign tumors that originate from Schwann cells, in the nervous system. Symptoms can include [[hearing loss]], [[balance problems]], and [[ringing in the ears]] (tinnitus). Treatment options for neurofibromatosis type II include surgery, [[radiation therapy]], and [[chemotherapy]].
+Merlin is a [[tumor suppressor]] protein that is involved in the regulation of [[cell growth]] and [[cell adhesion]]. It plays a critical role in maintaining the stability of [[cell junctions]] and the [[cytoskeleton]]. Merlin is known to inhibit the [[Ras signaling pathway]], which is important for controlling cell proliferation.
-[[File:Merlin protein structure.jpg|thumb|right|300px|Structure of the Merlin protein. The FERM domain (blue) interacts with the cell membrane, while the alpha-helical (green) and C-terminal (red) domains are involved in protein-protein interactions.]]
+== Clinical significance ==
+Mutations in the NF2 gene can lead to the development of [[neurofibromatosis type II]], a disorder characterized by the growth of noncancerous tumors in the [[nervous system]], particularly [[schwannomas]] and [[meningiomas]]. Patients with neurofibromatosis type II often experience [[hearing loss]], [[balance problems]], and other neurological symptoms.
-==See also==
+== Interactions ==
-* [[Neurofibromatosis]]
+Merlin interacts with several other proteins, including [[CD44]], [[beta-catenin]], and [[Rac1]]. These interactions are important for its role in cell signaling and maintaining cell structure.
-* [[Tumor suppressor]]
-* [[Schwann cell]]
-==References==
+== Research ==
+Ongoing research is focused on understanding the precise mechanisms by which merlin functions as a tumor suppressor and how its loss leads to tumor development. Studies are also exploring potential therapeutic strategies to target merlin-deficient tumors.
+== See also ==
+* [[Neurofibromatosis type II]]
+* [[Tumor suppressor gene]]
+* [[ERM family]]
+== References ==
 <references />
+== External links ==
+* [https://www.ncbi.nlm.nih.gov/gene/4771 NF2 gene - NCBI]
+* [https://www.uniprot.org/uniprot/P35240 Merlin - UniProt]
 [[Category:Proteins]]
-[[Category:Genes]]
+[[Category:Tumor suppressor genes]]
-[[Category:Neurology]]
+[[Category:Neurofibromatosis]]
-[[Category:Oncology]]
-{{medicine-stub}}